Locus coeruleus
暂无分享,去创建一个
[1] D. Surmeier,et al. Mitochondrial oxidant stress in locus coeruleus is regulated by activity and nitric oxide synthase , 2014, Nature Neuroscience.
[2] Roger A. Barker,et al. Targeting impulsivity in Parkinson’s disease using atomoxetine , 2014, Brain : a journal of neurology.
[3] W. Poewe,et al. The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[4] D. McCormick,et al. Neurotransmitter actions in the thalamus and cerebral cortex. , 1992, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[5] Suneil K. Kalia,et al. The effect of dexmedetomidine on the firing properties of STN neurons in Parkinson's disease , 2015, The European journal of neuroscience.
[6] Xin Wang,et al. Optogenetic Stimulation of Locus Ceruleus Neurons Augments Inhibitory Transmission to Parasympathetic Cardiac Vagal Neurons via Activation of Brainstem α1 and β1 Receptors , 2014, The Journal of Neuroscience.
[7] C. Brayne,et al. Depression in the elderly: pathological study of raphe and locus ceruleus , 2005, Neuropathology and applied neurobiology.
[8] Luca Mainardi,et al. Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease , 2016, Front. Aging Neurosci..
[9] T. Robbins,et al. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. , 1993, Brain : a journal of neurology.
[10] Antoine Adamantidis,et al. Sleep Homeostasis Modulates Hypocretin-Mediated Sleep-to-Wake Transitions , 2009, The Journal of Neuroscience.
[11] Ee Peng Lim,et al. Locus coeruleus stimulation and noradrenergic modulation of hippocampo-prefrontal cortex long-term potentiation. , 2010, The international journal of neuropsychopharmacology.
[12] Daniel O'Connor,et al. Laminar, tangential and regional organization of the noradrenergic innervation of monkey cortex: Dopamine-β-hydroxylase immunohistochemistry , 1982, Brain Research Bulletin.
[13] Shosuke Ito,et al. Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus , 2015, Journal of neurochemistry.
[14] S. Kish,et al. Thalamic noradrenaline in Parkinson's disease: Deficits suggest role in motor and non‐motor symptoms , 2012, Movement disorders : official journal of the Movement Disorder Society.
[15] Wenjun Gao,et al. Norepinephrine versus dopamine and their interaction in modulating synaptic function in the prefrontal cortex , 2016, Brain Research.
[16] J. D. McGaugh,et al. Memory modulation. , 2011, Behavioral neuroscience.
[17] Abdelhamid Benazzouz,et al. Noradrenaline and Parkinson's Disease , 2011, Front. Syst. Neurosci..
[18] R. Dolan,et al. Beta-adrenergic modulation of emotional memory-evoked human amygdala and hippocampal responses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] A. Björklund,et al. Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease , 2014, Experimental Neurology.
[20] Qingshan Wang,et al. A novel role of microglial NADPH oxidase in mediating extra‐synaptic function of norepinephrine in regulating brain immune homeostasis , 2015, Glia.
[21] Dorothee P Auer,et al. In Vivo Assessment of Brainstem Depigmentation in Parkinson Disease: Potential as a Severity Marker for Multicenter Studies. , 2017, Radiology.
[22] Chris Zarow,et al. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. , 2003, Archives of neurology.
[23] R. Takahashi,et al. Immunohistochemical localization of apoptosome-related proteins in Lewy bodies in Parkinson׳s disease and dementia with Lewy bodies , 2014, Brain Research.
[24] Peter A LeWitt,et al. Norepinephrine: the next therapeutics frontier for Parkinson's disease , 2012, Translational Neurodegeneration.
[25] K. Rommelfanger,et al. Norepinephrine: The redheaded stepchild of Parkinson's disease. , 2007, Biochemical pharmacology.
[26] J. Cohen,et al. The role of locus coeruleus in the regulation of cognitive performance. , 1999, Science.
[27] W. Hare,et al. Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity. , 2008, Investigative ophthalmology & visual science.
[28] J. Aceves,et al. Noradrenaline increases the firing rate of a subpopulation of rat subthalamic neurones through the activation of α1-adrenoceptors , 2003, Neuropharmacology.
[29] Roger A. Barker,et al. Improving Response Inhibition in Parkinson’s Disease with Atomoxetine , 2015, Biological Psychiatry.
[30] K. Kendrick,et al. Human amygdala reactivity is diminished by the β-noradrenergic antagonist propranolol , 2010, Psychological Medicine.
[31] P. Crenna,et al. Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease , 2011, BMC neurology.
[32] David J. Brooks,et al. Progression of monoaminergic dysfunction in Parkinson's disease: A longitudinal 18F-dopa PET study , 2011, NeuroImage.
[33] M. Nedergaard,et al. Distinct Functional States of Astrocytes During Sleep and Wakefulness: Is Norepinephrine the Master Regulator? , 2015, Current Sleep Medicine Reports.
[34] P. Goldman-Rakic,et al. Selective prefrontal cortical projections to the region of the locus coeruleus and raphe nuclei in the rhesus monkey , 1984, Brain Research.
[35] P. Sawchenko,et al. Noradrenergic Innervation of the Dorsal Medial Prefrontal Cortex Modulates Hypothalamo-Pituitary-Adrenal Responses to Acute Emotional Stress , 2008, The Journal of Neuroscience.
[36] Jisook Moon,et al. Alpha-synuclein interferes with cAMP/PKA-dependent upregulation of dopamine β-hydroxylase and is associated with abnormal adaptive responses to immobilization stress , 2014, Experimental Neurology.
[37] H. Braak,et al. Lewy pathology and neurodegeneration in premotor Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[38] S. Foote,et al. Distribution of dopamine β‐hydroxylase‐like immunoreactive fibers within the shell subregion of the nucleus accumbens , 1997, Synapse.
[39] Y. Agid,et al. Idazoxan, an alpha‐2 antagonist, and L‐DOPA‐induced dyskinesias in patients with Parkinson's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.
[40] Tadeusz Sarna,et al. Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease , 2017, Progress in Neurobiology.
[41] D. Qiu,et al. Effects of norepinephrine on spontaneous firing activity of cerebellar Purkinje cells in vivo in mice , 2016, Neuroscience Letters.
[42] W. Drinkenburg,et al. Anti-Parkinson effects of a selective alpha2C-adrenoceptor antagonist in the MPTP marmoset model , 2014, Behavioural Brain Research.
[43] A. Russo-Neustadt,et al. Norepinephrine and nitric oxide promote cell survival signaling in hippocampal neurons. , 2010, European journal of pharmacology.
[44] R. Wise,et al. Dopamine Uptake through the Norepinephrine Transporter in Brain Regions with Low Levels of the Dopamine Transporter: Evidence from Knock-Out Mouse Lines , 2002, The Journal of Neuroscience.
[45] Y. Smith,et al. Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys , 2017, Neurobiology of Disease.
[46] David P. Friedman,et al. Norepinephrinergic afferents and cytology of the macaque monkey midline, mediodorsal, and intralaminar thalamic nuclei , 2008, Brain Structure and Function.
[47] K. Ressler,et al. Role of Norepinephrine in the Pathophysiology of Neuropsychiatric Disorders , 2001, CNS Spectrums.
[48] Megan M. Risi,et al. Frontal and posterior subtypes of neuropsychological deficit in Parkinson's disease. , 2013, Behavioral neuroscience.
[49] K. Fuxe,et al. Localization of monoamines in the lower brain stem , 1964, Experientia.
[50] E. Bézard,et al. Effect of the α2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey , 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[51] Eduardo E. Benarroch,et al. The locus ceruleus norepinephrine system , 2009, Neurology.
[52] J. Kulisevsky,et al. Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances , 2009, Journal of Neural Transmission.
[53] C. Marín,et al. Effect of locus coeruleus denervation on levodopa-induced motor fluctuations in hemiparkinsonian rats , 2008, Journal of Neural Transmission.
[54] D. Surmeier,et al. A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[55] Angela J. Yu,et al. Phasic norepinephrine: A neural interrupt signal for unexpected events , 2006, Network.
[56] T. McHugh,et al. Noradrenergic modulation of evoked dopamine release and pH shift in the mouse dorsal hippocampus and ventral striatum , 2017, Brain Research.
[57] E. Lindberg,et al. Differential degeneration of the locus coeruleus in dementia subtypes. , 2011, Clinical neuropathology.
[58] S. Kalinin,et al. Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta , 2007, Journal of neurochemistry.
[59] Denise Manahan-Vaughan,et al. β-Adrenergic Control of Hippocampal Function: Subserving the Choreography of Synaptic Information Storage and Memory , 2016, Cerebral cortex.
[60] M. Palkovits,et al. Peptidergic innervation of the locus coeruleus cells in the human brain , 1990, Brain Research.
[61] M. Atzori,et al. Locus Ceruleus Norepinephrine Release: A Central Regulator of CNS Spatio-Temporal Activation? , 2016, Front. Synaptic Neurosci..
[62] G. Chrousos. Stress and disorders of the stress system , 2009, Nature Reviews Endocrinology.
[63] A. Benazzouz,et al. Activation of subthalamic alpha 2 noradrenergic receptors induces motor deficits as a consequence of neuronal burst firing , 2012, Neurobiology of Disease.
[64] G. Miller,et al. Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice , 2007, Proceedings of the National Academy of Sciences.
[65] B. Waterhouse,et al. Reciprocal connections between subdivisions of the dorsal raphe and the nuclear core of the locus coeruleus in the rat , 2004, Brain Research.
[66] O. Lindvall,et al. The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. , 1974, Acta physiologica Scandinavica. Supplementum.
[67] Yasuo Terayama,et al. Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging. , 2014, Parkinsonism & related disorders.
[68] S. Sara,et al. Network reset: a simplified overarching theory of locus coeruleus noradrenaline function , 2005, Trends in Neurosciences.
[69] D. Lindenbach,et al. Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to l-DOPA in the hemi-parkinsonian rat , 2014, Behavioural Brain Research.
[70] Marie Vidailhet,et al. The coeruleus/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder. , 2016, Brain : a journal of neurology.
[71] V. Chan‐Palay,et al. Quantitation of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression , 1989, The Journal of comparative neurology.
[72] C. Berridge,et al. The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes , 2003, Brain Research Reviews.
[73] J. Morrison,et al. Noradrenergic innervation of the hypothalamus of rhesus monkeys: Distribution of dopamine‐β‐hydroxylase immunoreactive fibers and quantitative analysis of varicosities in the paraventricular nucleus , 1993, The Journal of comparative neurology.
[74] Habib Benali,et al. The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson’s disease , 2013, Brain : a journal of neurology.
[75] Georg Auburger,et al. The Brainstem Pathologies of Parkinson's Disease and Dementia with Lewy Bodies , 2015, Brain pathology.
[76] E. Peskind,et al. Preservation of Noradrenergic Neurons in the Locus Ceruleus that Coexpress Galanin mRNA in Alzheimer's Disease , 1999, Journal of neurochemistry.
[77] Yasuo Terayama,et al. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging , 2013, Neuroscience Letters.
[78] P. Luppi,et al. New aspects in the pathophysiology of rapid eye movement sleep behavior disorder: the potential role of glutamate, gamma-aminobutyric acid, and glycine. , 2013, Sleep medicine.
[79] B. Berger,et al. Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine‐beta‐hydroxylase , 1989, The Journal of comparative neurology.
[80] Wade K. Smith,et al. Disease‐specific patterns of locus coeruleus cell loss , 1992, Annals of neurology.
[81] D. Bennett,et al. Brainstem aminergic nuclei and late-life depressive symptoms. , 2013, JAMA psychiatry.
[82] Qunyuan Xu,et al. Lesion of the locus coeruleus aggravates dopaminergic neuron degeneration by modulating microglial function in mouse models of Parkinson׳s disease , 2015, Brain Research.
[83] W. Oertel,et al. A concerted action of L- and T-type Ca2+ channels regulates locus coeruleus pacemaking , 2015, Molecular and Cellular Neuroscience.
[84] A. Lees,et al. Cognitive deficits in the early stages of Parkinson's disease. , 1983, Brain : a journal of neurology.
[85] P. Bonaventure,et al. OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2‐INDUCED PANIC‐ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES , 2015, Depression and anxiety.
[86] Y. Miyashita,et al. Medial prefrontal activity during shifting under novel situations , 2010, Neuroscience Letters.
[87] T. Horvath,et al. Orexin neuronal changes in the locus coeruleus of the aging rhesus macaque , 2007, Neurobiology of Aging.
[88] G. Leichnetz. Afferent and efferent connections of the dorsolateral precentral gyrus (area 4, hand/arm region) in the macaque monkey, with comparisons to area 8 , 1986, The Journal of comparative neurology.
[89] T. Joh,et al. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease , 1990, Annals of neurology.
[90] G. Paxinos,et al. The substantia nigra and ventral tegmental dopaminergic neurons from development to degeneration , 2016, Journal of Chemical Neuroanatomy.
[91] Wade G. Regehr,et al. Noradrenergic Control of Associative Synaptic Plasticity by Selective Modulation of Instructive Signals , 2009, Neuron.
[92] J. Morrison,et al. Noradrenergic innervation of monkey prefrontal cortex: A dopamine‐β‐hydroxylase immunohistochemical study , 1989, The Journal of comparative neurology.
[93] H. Eichenbaum,et al. Noradrenergic, but not cholinergic, deafferentation of prefrontal cortex impairs attentional set-shifting , 2008, Neuroscience.
[94] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[95] F. Colpaert,et al. Effects of (+/-)-idazoxan alone and in combination with L-DOPA methyl ester in MPTP-induced hemiparkinsonian monkeys. , 2003, Receptors & channels.
[96] H. Groenewegen,et al. The Proteome of the Locus Ceruleus in Parkinson's Disease: Relevance to Pathogenesis , 2012, Brain pathology.
[97] S. Lewis,et al. Pathology of behavior in PD : What is known and what is not ? , 2022 .
[98] A. C. Roberts,et al. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: Evidence for a specific attentional dysfunction , 1989, Neuropsychologia.
[99] U. Ungerstedt,et al. Noradrenaline Nerve Terminals in Human Cerebral Cortices: First Histochemical Evidence , 1972, Science.
[100] Hye-Sun Kim,et al. Norepinephrine provides short-term neuroprotection against Aβ1–42 by reducing oxidative stress independent of Nrf2 activation , 2014, Neurobiology of Aging.
[101] B D Waterhouse,et al. New perspectives on the functional organization and postsynaptic influences of the locus ceruleus efferent projection system. , 1998, Advances in pharmacology.
[102] E. Bézard,et al. Noradrenergic Modulation of Subthalamic Nucleus Activity: Behavioral and Electrophysiological Evidence in Intact and 6-Hydroxydopamine-Lesioned Rats , 2007, The Journal of Neuroscience.
[103] Udo Rüb,et al. Where Does Parkinson Disease Pathology Begin in the Brain? , 2002, Journal of neuropathology and experimental neurology.
[104] A. Arnsten,et al. Neuromodulation of Thought: Flexibilities and Vulnerabilities in Prefrontal Cortical Network Synapses , 2012, Neuron.
[105] A. Erisir,et al. Monosynaptic Glutamatergic Activation of Locus Coeruleus and Other Lower Brainstem Noradrenergic Neurons by the C1 Cells in Mice , 2013, The Journal of Neuroscience.
[106] Xiaoping Hu,et al. Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach. , 2014, Magnetic resonance imaging.
[107] Jian Liu,et al. Firing activity of locus coeruleus noradrenergic neurons increases in a rodent model of Parkinsonism , 2009, Neuroscience bulletin.
[108] K. Ye,et al. Norepinephrine Protects against Amyloid-beta Toxicity via TrkB , 2022 .
[109] M. Raskind,et al. Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease , 2011, Brain Research.
[110] M. Husain,et al. Noradrenergic modulation of space exploration in visual neglect , 2006, Annals of neurology.
[111] M. Corbetta,et al. The Reorienting System of the Human Brain: From Environment to Theory of Mind , 2008, Neuron.
[112] S. Foote,et al. Noradrenergic and serotoninergic innervation of cortical, thalamic, and tectal visual structures in old and new world monkeys , 1986, The Journal of comparative neurology.
[113] S Patt,et al. A Golgi study of human locus coeruleus in normal brains and in Parkinson's disease , 1993, Neuropathology and applied neurobiology.
[114] Nora Turjanski,et al. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. , 2005, Brain : a journal of neurology.
[115] S. Foote,et al. Extrathalamic modulation of cortical function. , 1987, Annual review of neuroscience.
[116] C. Tai,et al. Neuronal firing patterns outweigh circuitry oscillations in parkinsonian motor control. , 2016, The Journal of clinical investigation.
[117] W. Schmidt,et al. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6‐hydroxydopamine‐induced partial degeneration of substantia nigra in rats , 2003, The European journal of neuroscience.
[118] U. Schambra,et al. Neuron specific α-adrenergic receptor expression in human cerebellum: Implications for emerging cerebellar roles in neurologic disease , 2005, Neuroscience.
[119] T. Robbins,et al. Functions of frontostriatal systems in cognition: Comparative neuropsychopharmacological studies in rats, monkeys and humans , 2006, Biological Psychology.
[120] F. Tempia,et al. Noradrenergic modulation of the parallel fiber-Purkinje cell synapse in mouse cerebellum , 2015, Neuropharmacology.
[121] Jonathan D. Cohen,et al. An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. , 2005, Annual review of neuroscience.
[122] Mark A. Eckert,et al. Histologic validation of locus coeruleus MRI contrast in post-mortem tissue , 2015, NeuroImage.
[123] A. Parent,et al. The monoaminergic innervation of the amygdala in the squirrel monkey: An immunohistochemical study , 1990, Neuroscience.
[124] G. Miller,et al. Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus , 2014, Neuropharmacology.
[125] Gary Aston-Jones,et al. The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease , 2012, Front. Behav. Neurosci..
[126] Hiroshi Fukuda,et al. Attentional Set-Shifting Deficit in Parkinson’s Disease Is Associated with Prefrontal Dysfunction: An FDG-PET Study , 2012, PloS one.
[127] J. D. Coulter,et al. Descending projections of the locus coeruleus and subcoeruleus/medial parabrachial nuclei in monkey: Axonal transport studies and dopamine-β-hydroxylase immunocytochemistry , 1980, Brain Research Reviews.
[128] Jun Lu,et al. Locus Ceruleus and Anterior Cingulate Cortex Sustain Wakefulness in a Novel Environment , 2010, The Journal of Neuroscience.
[129] J. Allman,et al. Comparative anatomy of the locus coeruleus in humans and nonhuman primates , 2010, The Journal of comparative neurology.
[130] V. Fung,et al. Unilateral rest tremor in vascular parkinsonism associated with a contralateral lesion of the locus coeruleus , 2009, Movement disorders : official journal of the Movement Disorder Society.
[131] A. Craig,et al. Association of spinal lamina I projections with brainstem catecholamine neurons in the monkey , 1996, Experimental Brain Research.
[132] M. Vila,et al. Selective noradrenergic vulnerability in alpha-synuclein transgenic mice , 2010, Neurobiology of Aging.